NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Intract Pharma

Intract Pharma

Private
LondonHealthcare & Life Scienceshttps://www.intractpharma.com/

Last Round

Corporate Funding

Sep 16, 2024

Total Funding Raised

$3.87M

Company Overview

Intract Pharma is a biotechnology company that develops and licenses oral drug delivery technologies to replace injectable medicines.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

oral drug deliveryoral biologicsdrug delivery platformlarge molecule deliveryoral formulationbiologic pillscolon-targeted deliveryoral monoclonal antibodiesoral mAbsGI drug deliverytechnology licensingoral peptidesinflammatory bowel diseaseIBD treatmentin-vitro GI models

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Intract Pharma Comparables

Compare Intract Pharma with similar companies based on industry and business-model similarity.

Intract Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Panarum Corp
86%
Bhami's Research Laboratory Private Limited
83%
Plantibodies
82%

Intract Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingSep 16, 2024
GrantMay 28, 2024
Corporate FundingMay 26, 2020
GrantNov 9, 2018
SeedJan 11, 2016

Key People

Founding team and executive leadership

Vipul Yadav

Chief Executive Officer

Executive Team

Intract Pharma Investors

Notable investors and investment history

Intract Pharma investors
InvestorRounds
Eurostars SME programmeGrant
Innovate UKGrant
UCL BusinessSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Monthly visitors increased 305% MoM, reaching 4.7K.

  • May 1, 2025

    Monthly visitors increased 586% MoM.

Intract Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Intract Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Intract Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range14
Year Founded2015
Last FundingSep 16, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.